Pantoflux (Pantoprazole)

Pantoprazole, the active ingredient in Pantoflux, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults. GNH USA supplies Pantoflux as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoflux as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Erosive esophagitis: heals existing ulcerations in the esophageal lining. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with this rare neuroendocrine tumor. - Peptic ulcer disease (duodenal and gastric ulcers): supports ulcer healing and reduces recurrence risk. - Maintenance therapy after healed erosive esophagitis: helps prevent relapse of symptoms.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas formation. - Constipation: infrequent.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile infection: may present with watery diarrhea. - Low magnesium levels (hypomagnesemia): can cause muscle cramps or arrhythmia. - Bone fracture risk with long‑term use: especially in elderly patients. - Liver enzyme elevation: indicates possible hepatic involvement. - Acute interstitial nephritis: rare kidney inflammation.

Before starting Pantoflux, consider the following safety points: - Assess renal function: dose adjustment may be needed in severe impairment. - Review liver disease status: use with caution in moderate to severe hepatic impairment. - Evaluate need for long‑term therapy: prolonged use may increase fracture risk. - Monitor for magnesium levels: especially if therapy exceeds three months. - Consider drug‑interaction potential: check concomitant medications for CYP‑related effects. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir: decreased antiviral exposure. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Digoxin: slight rise in serum levels. - Methotrexate: reduced renal clearance at high doses. - Mycophenolate mofetil: increased exposure. - Iron supplements: lower iron absorption when taken simultaneously.